Suneel Kamath on Muck Rack

Suneel Kamath

  • Fellow - Northwestern Medicine
Cleveland
As seen in: Wiley, Wiley Online Library, The Oncologist, Chicago Tribune, MDPI, U.S. News and World Report, STAT, MedPage Today, Healio Gastroenterology, HemOnc Today and
GI #Oncologist @ClevelandClinic

Get in touch with Suneel

Contact Suneel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

The Advent of Perioperative Immunotherapy in Early-Stage Hepatocellular Carcinoma

|
By Suneel Kamath
| NEJM Journal Watch Verified
Suneel D. Kamath, M.D., reviewing Perioperative camrelizumab plus rivoceranib more than doubles event-free survival compared with surgery alone in select patients with hepatocellular carcinoma. Even with optimal surgical resection, up to 80% of patients with early-stage hepatocellular carcinoma (HCC) experience recurrence, particularly those with bulky tumors or vascular invasion. Numerous adjuvant therapies, including atezolizumab and bevacizumab, have failed to improve outcomes.
Open in Who Shared Issue with article?

Exercise as Medicine for Preventing Colon Cancer Recurrence

|
By Suneel Kamath, Vlad G. Zaha
| NEJM Journal Watch Verified
Suneel D. Kamath, MD and Vlad G. Zaha, MD, PhD, FACC, FAHA, reviewing Structured exercise significantly reduces recurrence risk and improves survival for stage II and III colon cancer. While outcomes after surgery and adjuvant chemotherapy for stage II/III colon cancer are generally good, cancer still recurs in about 30% of patients, and quality of life and cardiorespiratory fitness are decreased.
Open in Who Shared Issue with article?

‘Persuasive’ data show screening high-risk individuals improves pancreatic cancer outcomes

|
By Josh Friedman, Mindy Valcarcel, Suneel Kamath
| HemOnc Today Verified
Suneel Kamath, MD This study is a big positive. Pancreatic cancer is such a deadly disease, so anything we can do to detect it earlier is going to translate into positive outcomes. The difference in median OS jumps off the page. You don’t see differences like that in most studies. It is a massive difference in mortality rate, and it was a bigger magnitude of improvement than I would’ve expected.
Open in Who Shared Issue with article?
See all 50 licensed articles (78 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified